News

Gilead Sciences: Dividend Investors Must Be Cautious
Gilead Sciences offers steady dividend growth with a 2.99% yield. Read why the analyst nonetheless has a neutral rating on ...
India may seek parity with US on tech access in bilateral trade pact talks: Sources
India is likely to ask the US to ease export controls and grant it access to critical technologies on par with key American allies like Australia, the UK, and Japan under the proposed bilateral trade ...
American Association of Individual Investors2d
Why MAIA Biotechnology, Inc.’s (MAIA) Stock Is Down 6.67%
MAIA Biotechnology, Inc.’s MAIA share price has dipped by 6.67%, which has investors questioning if this is right time to buy ...
MoneyWeek2d
Precision-engineered profits: How to invest in genomics
Developments in genomics are enabling the rise of personalised medicine, with therapies tailored specifically for individuals ...
The Harvard Crimson2d
Harvard Built the Biotech Industry in Cambridge, Then Let It Go. Now It Wants Back In.
Kendall Square has become a hub of biotech innovation and a popular location for up and coming life sciences firms. Now, a ...
Tech Break on MSN3d
U.S. report reveals China’s plans to develop an army of robot soldiers with advanced AI
A report from the United States revealed that China is planning to develop a powerful army of robot soldiers powered by AI. O post U.S. report reveals China’s plans to develop an army of robot ...
NASA’s Perseverance Rover Reveals Mars’ Volcanic Past – And Hints of Ancient Life
A team of scientists has uncovered new details about Mars’ Jezero Crater using the Perseverance rover's cutting-edge ...
Scientists claim to have found evidence of alien life. But ‘biosignatures’ might hide more than they reveal
The researchers found strong evidence of a chemical called dimethyl sulfide (DMS) in the planet’s atmosphere. On Earth, DMS ...
American Association of Individual Investors4d
Why Sana Biotechnology, Inc.’s (SANA) Stock Is Up 7.80%
Sana Biotechnology, Inc.’s SANA share price has surged by 7.80%, which has investors questioning if this is right time to sell.
ncbiotech.org5d
Seqirus Inks Federal Contract to Develop Two Pandemic Flu Vaccines
The $1 billion-plus facility can supply more than 150 million doses of vaccine to support a pandemic response. The North Carolina Biotechnology Center was involved in recruiting the manufacturing ...
Gene syntax shown to control variability in synthetic plasmids
Engineers and biologists at Dartmouth College have found that, just like word order affects meaning in a sentence, the ...